Rofecoxib (Vioxx) voluntarily withdrawn from market.
Sibbald
Barbara
B
D004345:Drug Industry; D004335:Drug and Narcotic Control; D006801:Humans; D007783:Lactones / Q000009:adverse effects* / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D020521:Stroke / Q000139:chemically induced* / Q000401:mortality; D013450:Sulfones; D016019:Survival Analysis; D014481:United States
D007783:Lactones; D013450:Sulfones; C116926:rofecoxib